References
- Kiloh L G. Non-pharmacological biological treatments of psychiatric patients. Australian and New Zealand Journal of Psychiatry 1983; 17: 215–225
- Varghese F TN, Sing B S. Electroconvulsive therapy in 1985a review. The Medical Journal of Australia 1985; 143: 192–196
- Janicak P G, Davis J M, Gibbons R D, Ericksen S, Chang S, Gallagher D. Efficacy of ECT: A meta-analysis. American Journal of Psychiatry 1985; 142: 297–302
- Kerr R A, McGrath J J, O'Kearney R T, Price J. ECT: Misconceptions and attitudes. Australian and New Zealand Journal of Psychiatry 1982; 16: 43–49
- Durham J. Inadequate provision for electroconvulsive therapy in the New South Wales Mental Health Act 1983. Australian and New Zealand Journal of Psychiatry 1988; 22: 404–411
- Edwards G E, Flaherty B. Electro-convulsive therapy: A new era of controversy. Australian and New Zealand Journal of Psychiatry 1978; 12: 161–164
- Mendelson G. Electrotherapy and “placebo” electrotherapy. The Medical Journal of Australia 1981; 2: 125–128
- NHMRC Report Electroconvulsive therapy. The Medical Journal of Australia 1985; 143: 190–191
- Thomas A, Goldney R, Phillips P. Depression, anticonvulsive therapy and diabetes mellitus. Australian and New Zealand Journal of Psychiatry 1983; 17: 289–291
- Parker G. August, 1988, Steering Committee on Mental Health: Process issues. The Royal Australian and New Zealand College of Psychiatrists, NSW Branch Newsletter
- The Royal College of Psychiatrists. Memorandum on the use of electroconvulsive therapy. British Journal of Psychiatry 1977; 131: 261–272
- Kendell R E. The present status of electroconvulsive therapy. British Journal of Psychiatry 1981; 139: 265–283
- Consensus conference Electroconvulsive therapy. Journal of the American Medical Association 1985; 254: 2103–2108
- Markowitz J, Brown R, Sweeney J, Mann J. Reduced length and cost of hospital stay for major depression in patients treated with ECT. American Journal of Psychiatry 1987; 144: 1025–1029
- Ulett G, Smith K, Glesser G C. Evaluation of convulsive and sub-convulsive shock therapies utilizing a control group. American Journal of Psychiatry 1956; 112: 795–802
- Ottosson J O. Seizure characteristics and therapeutic efficacy in electroconvulsive therapy: An analysis of the antidepressive efficiency of grand mal and lidocaine-modified seizures. Journal of Nervous and Mental Disease 1962; 135: 239–251
- Freeman C PL, Basson J V, Crichton A. A double blind controlled trial of electroconvulsive therapy (ECT) and simulated ECT in depressive illness. Lancet 1978; 1: 738–740
- Fink M. Convulsive therapy. Raven Press, New York 1979
- Cronholm B, Ottosson J O. Experimental studies of the therapeutic action of electroconvulsive therapy in endogenous depression. Acta Psychiatrica Scandinavica 1960; 69–97, suppl 145
- Maletzky B M. Seizure duration and clinical effect in electroconvulsive therapy. Comprehensive Psychiatry 1978; 19: 541–550
- Kramer B A. Seizure parameters in depressed patients receiving electroconvulsive therapy: A pilot study. Comprehensive Psychiatry 1983; 24: 259–261
- Sackeim H, Decima P, Prohovnik I, Malitz S. Seizure threshold in electroconvulsive therapy: Effects of sex, age, electrode placement and number of treatments. Archives of General Psychiatry 1987; 44: 355–360
- Bergsholm P, Gran L, Bleie H. Seizure duration in unilateral electroconvulsive therapy. Acta Psychiatrica Scandinavica 1984; 69: 121–128
- Shapira B, Lerer B, Gilboa D, Drexler H, Kugelmass S., Calev A. Facilitation of ECT by caffeine pretreatment. American Journal of Psychiatry 1987; 144: 1199–1202
- Imlah N W, Ryan E, Harrigton J A. The influence of antidepres-sant drugs on the response to ECT and on the subsequent relapse rates. Psychopharmacology 1965; 4: 438–442
- Stromgren L S, Dahl J, Fjeldborg N, Thomsem A. Factors influencing seizure duration and number of seizures applied in unilateral electroconvulsive therapy: Anaesthetics and ben-zodiazepines. Acta Psychiatrica Scandinavica 1980; 62: 159–165
- Miller A L, Faber R A, Hatch J P, Alexander H E. Factors affecting amnesia, seizure duration, and efficacy in ECT. American Journal of Psychiatry 1985; 142: 692–696
- Standish-Barry H MAS, Deacon V, Snaith R P. The relationship of concurrent benzodiazepine administration to seizure duration in ECT. Acta Psychiatrica Scandinavica 1985; 71: 269–271
- Fink M. Convulsive therapy in affective disorders: A decade of understanding and acceptance. Psychopharmacology: The third generation of progress, H Y Meltzer. Raven Press, New York 1987
- Latey R H, Fahy J. Some influences on regional variation in frequency of prescription of electroconvulsive therapy. British Journal of Psychiatry 1988; 152: 196–200
- Thompson J W, Blaine J D. Use of ECT in the United States in 1975 and 1980. American Journal of Psychiatry 1987; 144: 557–562
- Tancer M E, Golden R N, Ekstrom R D, Evans D L. Use of electroconvulsive therapy at a university hospital: 1970and 1980–81. Hospital and Community Psychiatry 1989; 40: 64–68
- Fink M, Johnson L. Monitoring duration of ECT seizure: “cuff and EEG methods compared”. Archives of General Psychiatry 1982; 39: 119–1191
- Bamngton P, Lambourn J. Monitoring the occurrence and duration of electroconvulsive fits. British Journal of Psychiatry 1987; 151: 118–119
- Dunlop E. Combination of antidepressant with electroshock therapy. Diseases of the Nervous System 1960; 21: 513–514
- Turek I S. Combined use of ECT and psychotropic drugs: an-tidepressives and antipsychotics. Comprehensive Psychiatry 1973; 14: 495–501
- Seager C P, Bird R L. lmipramine with electrical treatment in depression: A controlled trial. Journal of Mental Science 1962; 108: 704–707
- d'Elia G, Ottosson J, Stromgreen L S. Present practice of electroconvulsive therapy in Scandinavia. Archives of General Psychiatry 1983; 40: 577–581
- Gordon D. Electroconvulsive therapy with minimum hazard. British Journal of psychiatry 1982; 141: 12–18